May 17th 2024
Dive in and learn more about the answers to yesterday’s quiz.
FDA Approves Omalizumab Injection for Treatment of Food Allergies
February 20th 2024The approval was based on positive data from a phase 3 trial that showed patients treated with omalizumab were significantly more likely to tolerate peanut, milk, egg, or cashew protein without moderate to severe allergic symptoms.
Oral Immunotherapy for Common Food Allergies Receives FDA Fast Track Designation
November 28th 2023ADP101 is designed to treat allergy to 1 or more of the world’s most significant allergens including cashew, almond, chicken’s egg, cow’s milk, codfish, peanut, pecan, pistachio, salmon, sesame, soy, shrimp, walnut and wheat.